Home  >  Products  >  RP9 (retinitis pigmentosa 9 (autosomal dominant) ) Blocking Peptide (the C terminal of RP9)(100ug)
RP9 (retinitis pigmentosa 9 (autosomal dominant) ) Blocking Peptide (the C terminal of RP9)(100ug)

RP9 (retinitis pigmentosa 9 (autosomal dominant) ) Blocking Peptide (the C terminal of RP9)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-RP9 Antibody (ARP63904_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP63904
Size: 100ug
Weight: 26kDa
Gene: 6100
Format: Lyophilized powder
Target: The protein encoded by this gene can be bound and phosphorylated by the protooncogene PIM1 product, a serine/threonine protein kinase . This protein localizes in nuclear speckles containing the splicing factors, and has a role in pre-mRNA splicing. CBF1-interacting protein (CIR), a corepressor of CBF1, can also bind to this protein and effects alternative splicing. Mutations in this gene result in autosomal dominant retinitis pigmentosa-9. This gene has a pseudogene (GeneID: 441212), which is located in tandem array approximately 166 kb distal to this gene.
Alternative names: PAP-1
See Full Product Listings >